Filing Flows

Filing Flows › Globus Medical (GMED) › Next earnings date

Globus Medical (GMED) earnings: beat the estimate

Globus Medical (GMED) reported on Nov 5, 2026 and beat the EPS estimate: $1.23 against $1.20 (+2.8%). Revenue was $764M for Q3 2026, -0.7% year over year. It beat the EPS estimate in 100% of the quarters on record.

Last result+2.8% vs estimate
Beat rate100%

The last report

Globus Medical reported revenue of $764M for the third quarter 2026 (-0.7% Y/Y), net earnings $141M: Musculoskeletal Solutions $729M, Enabling Technologies $34.9M. How it makes money → · Every quarter →

Globus Medical: EPS against the estimate, last 5 reportsGlobus Medical: EPS against the estimate, last 5 reportsEstimateReported$0.78$1.18Nov 25$1.15$1.28Feb 26$0.92$1.12May 26$1.10$1.34Aug 26$1.20$1.23Nov 26
Latest (Nov 26): Estimate $1.20, Reported $1.23.
GMED: the stock's move on each reportGMED: the stock's move on each reportAug 6, 2026+2.2%May 7, 2026-12.6%Feb 24, 2026+3.0%Nov 6, 2025+36.4%

Globus Medical's latest quarter

Globus Medical, Q3 2026: revenue $764M (-0.7% year over year), operating margin 23.2%, net earnings $141M, operating cash flow $265M. The chart follows the revenue to costs, profit and cash.

Questions

Did Globus Medical beat earnings?

Globus Medical (GMED) reported on Nov 5, 2026 and beat the EPS estimate: $1.23 against $1.20 (+2.8%).

When does GMED report earnings?

The next date is not set yet.

Does Globus Medical usually beat earnings?

It beat the consensus EPS estimate in 100% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.